{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MC", "RA", "gout", "hEDS", "hypermobile Ehlers\u2013Danlos syndrome", "mast cell", "psoriatic arthritis", "rheumatoid arthritis", "spondyloarthritis", "tendinopathy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37629547", "DateRevised": {"Year": "2023", "Month": "08", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "05"}], "Language": ["eng"], "ELocationID": ["1690", "10.3390/life13081690"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "13", "Issue": "8", "PubDate": {"Year": "2023", "Month": "Aug", "Day": "05"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Mast Cell Involvement in the Pathogenesis of Selected Musculoskeletal Diseases.", "Abstract": {"AbstractText": ["In recent years, there has been a noteworthy revival of interest in the function of mast cells (MCs) in the human body. It is now acknowledged that MCs impact a wide array of processes beyond just allergies, leading to a shift in research direction. Unfortunately, some earlier conclusions were drawn from animal models with flawed designs, particularly centered around the receptor tyrosine kinase (Kit) pathway. Consequently, several subsequent findings may have been unreliable. Thus, what is now required is a re-examination of these earlier findings. Nevertheless, the remaining data are fascinating and hold promise for a better comprehension of numerous diseases and the development of more effective therapies. As the field continues to progress, many intriguing issues warrant further investigation and analysis. For instance, exploring the bidirectional action of MCs in rheumatoid arthritis, understanding the extent of MCs' impact on symptoms associated with Ehlers-Danlos syndrome, and unraveling the exact role of the myofibroblast-mast cell-neuropeptides axis in the joint capsule during post-traumatic contractures are all captivating areas for exploration. Hence, in this review, we summarize current knowledge regarding the influence of MCs on the pathogenesis of selected musculoskeletal diseases, including rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, gout, muscle and joint injuries, tendinopathy, heterotopic ossification, and Ehlers-Danlos syndrome. We believe that this review will provide in-depth information that can guide and inspire further research in this area."]}, "AuthorList": [{"Identifier": ["0000-0002-5369-366X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Chemistry and Laboratory Medicine, Poznan University of Medical Sciences, Rokietnicka 8, 60-806 Poznan, Poland."}], "LastName": "Gutowski", "ForeName": "\u0141ukasz", "Initials": "\u0141"}, {"Identifier": ["0000-0002-4465-4183"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Chemistry and Laboratory Medicine, Poznan University of Medical Sciences, Rokietnicka 8, 60-806 Poznan, Poland."}], "LastName": "Kanikowski", "ForeName": "Szymon", "Initials": "S"}, {"Identifier": ["0000-0001-6691-3863"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Chemistry and Laboratory Medicine, Poznan University of Medical Sciences, Rokietnicka 8, 60-806 Poznan, Poland."}, {"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants-National Research Institute, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Formanowicz", "ForeName": "Dorota", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sigal L.H. Basic Science for the Clinician 53: Mast Cells. JCR J. Clin. Rheumatol. 2011;17:395\u2013400. doi: 10.1097/RHU.0b013e31823150b5.", "ArticleIdList": ["10.1097/RHU.0b013e31823150b5", "21952480"]}, {"Citation": "Mekori Y.A., Hershko A.Y. T Cell-Mediated Modulation of Mast Cell Function: Heterotypic Adhesion-Induced Stimulatory or Inhibitory Effects. Front. Immunol. 2012;3:6. doi: 10.3389/fimmu.2012.00006.", "ArticleIdList": ["10.3389/fimmu.2012.00006", "PMC3342371", "22566892"]}, {"Citation": "Walker M.E., Hatfield J.K., Brown M.A. New Insights into the Role of Mast Cells in Autoimmunity: Evidence for a Common Mechanism of Action? Biochim. Biophys. Acta BBA-Mol. Basis Dis. 2012;1822:57\u201365. doi: 10.1016/j.bbadis.2011.02.009.", "ArticleIdList": ["10.1016/j.bbadis.2011.02.009", "PMC4424662", "21354470"]}, {"Citation": "Singh J., Shah R., Singh D. Targeting Mast Cells: Uncovering Prolific Therapeutic Role in Myriad Diseases. Int. Immunopharmacol. 2016;40:362\u2013384. doi: 10.1016/j.intimp.2016.09.019.", "ArticleIdList": ["10.1016/j.intimp.2016.09.019", "27694038"]}, {"Citation": "Alvarez-Errico D., Yamashita Y., Suzuki R., Odom S., Furumoto Y., Yamashita T., Rivera J. Functional Analysis of Lyn Kinase A and B Isoforms Reveals Redundant and Distinct Roles in Fc\u03b5RI-Dependent Mast Cell Activation. J. Immunol. 2010;184:5000\u20135008. doi: 10.4049/jimmunol.0904064.", "ArticleIdList": ["10.4049/jimmunol.0904064", "PMC2948211", "20308635"]}, {"Citation": "Takai S., Jin D. Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9. Biomedicines. 2022;10:2499. doi: 10.3390/biomedicines10102499.", "ArticleIdList": ["10.3390/biomedicines10102499", "PMC9599306", "36289761"]}, {"Citation": "Zhao J., Guo S., Schrodi S.J., He D. Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications. Front. Immunol. 2021;12:790122. doi: 10.3389/fimmu.2021.790122.", "ArticleIdList": ["10.3389/fimmu.2021.790122", "PMC8660630", "34899757"]}, {"Citation": "Yu R., Zhang J., Zhuo Y., Hong X., Ye J., Tang S., Zhang Y. Identification of Diagnostic Signatures and Immune Cell Infiltration Characteristics in Rheumatoid Arthritis by Integrating Bioinformatic Analysis and Machine-Learning Strategies. Front. Immunol. 2021;12:724934. doi: 10.3389/fimmu.2021.724934.", "ArticleIdList": ["10.3389/fimmu.2021.724934", "PMC8526926", "34691030"]}, {"Citation": "Yu X., Kasprick A., Petersen F. Revisiting the Role of Mast Cells in Autoimmunity. Autoimmun. Rev. 2015;14:751\u2013759. doi: 10.1016/j.autrev.2015.04.008.", "ArticleIdList": ["10.1016/j.autrev.2015.04.008", "25913139"]}, {"Citation": "Feyerabend T.B., Weiser A., Tietz A., Stassen M., Harris N., Kopf M., Radermacher P., M\u00f6ller P., Benoist C., Mathis D., et al. Cre-Mediated Cell Ablation Contests Mast Cell Contribution in Models of Antibody- and T Cell-Mediated Autoimmunity. Immunity. 2011;35:832\u2013844. doi: 10.1016/j.immuni.2011.09.015.", "ArticleIdList": ["10.1016/j.immuni.2011.09.015", "22101159"]}, {"Citation": "Heger K., Fierens K., Vahl J.C., Aszodi A., Peschke K., Schenten D., Hammad H., Beyaert R., Saur D., Van Loo G., et al. A20-Deficient Mast Cells Exacerbate Inflammatory Responses In Vivo. PLoS Biol. 2014;12:e1001762. doi: 10.1371/journal.pbio.1001762.", "ArticleIdList": ["10.1371/journal.pbio.1001762", "PMC3891641", "24453940"]}, {"Citation": "Pitman N., Asquith D.L., Murphy G., Liew F.Y., McInnes I.B. Collagen-Induced Arthritis Is Not Impaired in Mast Cell-Deficient Mice. Ann. Rheum. Dis. 2011;70:1170\u20131171. doi: 10.1136/ard.2010.134528.", "ArticleIdList": ["10.1136/ard.2010.134528", "21131642"]}, {"Citation": "Adachi R., Krilis S.A., Nigrovic P.A., Hamilton M.J., Chung K., Thakurdas S.M., Boyce J.A., Anderson P., Stevens R.L. Ras Guanine Nucleotide-Releasing Protein-4 (RasGRP4) Involvement in Experimental Arthritis and Colitis. J. Biol. Chem. 2012;287:20047\u201320055. doi: 10.1074/jbc.M112.360388.", "ArticleIdList": ["10.1074/jbc.M112.360388", "PMC3370188", "22511759"]}, {"Citation": "Elliott E.R., Van Ziffle J.A., Scapini P., Sullivan B.M., Locksley R.M., Lowell C.A. Deletion of Syk in Neutrophils Prevents Immune Complex Arthritis. J. Immunol. 2011;187:4319\u20134330. doi: 10.4049/jimmunol.1100341.", "ArticleIdList": ["10.4049/jimmunol.1100341", "PMC3186826", "21918195"]}, {"Citation": "Mancardi D.A., J\u00f6nsson F., Iannascoli B., Khun H., Van Rooijen N., Huerre M., Da\u00ebron M., Bruhns P. Cutting Edge: The Murine High-Affinity IgG Receptor Fc\u03b3RIV Is Sufficient for Autoantibody-Induced Arthritis. J. Immunol. 2011;186:1899\u20131903. doi: 10.4049/jimmunol.1003642.", "ArticleIdList": ["10.4049/jimmunol.1003642", "21248252"]}, {"Citation": "Schubert N., Dudeck J., Liu P., Karutz A., Speier S., Maurer M., Tuckermann J., Dudeck A. Mast Cell Promotion of T Cell-Driven Antigen-Induced Arthritis Despite Being Dispensable for Antibody-Induced Arthritis in Which T Cells Are Bypassed: Mast Cell Promotion of Antigen-Induced Arthritis. Arthritis Rheumatol. 2015;67:903\u2013913. doi: 10.1002/art.38996.", "ArticleIdList": ["10.1002/art.38996", "25510234"]}, {"Citation": "Cunin P., Penke L.R., Thon J.N., Monach P.A., Jones T., Chang M.H., Chen M.M., Melki I., Lacroix S., Iwakura Y., et al. Megakaryocytes Compensate for Kit Insufficiency in Murine Arthritis. J. Clin. Investig. 2017;127:1714\u20131724. doi: 10.1172/JCI84598.", "ArticleIdList": ["10.1172/JCI84598", "PMC5409069", "28375155"]}, {"Citation": "Min H.K., Kim K.-W., Lee S.-H., Kim H.-R. Roles of Mast Cells in Rheumatoid Arthritis. Korean J. Intern. Med. 2020;35:12\u201324. doi: 10.3904/kjim.2019.271.", "ArticleIdList": ["10.3904/kjim.2019.271", "PMC6960056", "31722515"]}, {"Citation": "Suurmond J., Van Der Velden D., Kuiper J., Bot I., Toes R.E.M. Mast Cells in Rheumatic Disease. Eur. J. Pharmacol. 2016;778:116\u2013124. doi: 10.1016/j.ejphar.2015.03.085.", "ArticleIdList": ["10.1016/j.ejphar.2015.03.085", "25943290"]}, {"Citation": "Rivellese F., Mauro D., Nerviani A., Pagani S., Fossati-Jimack L., Messemaker T., Kurreeman F.A.S., Toes R.E.M., Ramming A., Rauber S., et al. Mast Cells in Early Rheumatoid Arthritis Associate with Disease Severity and Support B Cell Autoantibody Production. Ann. Rheum. Dis. 2018;77:1773\u20131781. doi: 10.1136/annrheumdis-2018-213418.", "ArticleIdList": ["10.1136/annrheumdis-2018-213418", "30127058"]}, {"Citation": "Rivellese F., Rossi F.W., Giorli G., Napolitano F., De Paulis A., Pitzalis C. Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment with Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs. Front. Pharmacol. 2020;11:1051. doi: 10.3389/fphar.2020.01051.", "ArticleIdList": ["10.3389/fphar.2020.01051", "PMC7371927", "32760275"]}, {"Citation": "Van Der Velden D., Lagraauw H.M., Wezel A., Launay P., Kuiper J., Huizinga T.W.J., Toes R.E.M., Bot I., Stoop J.N. Mast Cell Depletion in the Preclinical Phase of Collagen-Induced Arthritis Reduces Clinical Outcome by Lowering the Inflammatory Cytokine Profile. Arthritis Res. Ther. 2016;18:138. doi: 10.1186/s13075-016-1036-8.", "ArticleIdList": ["10.1186/s13075-016-1036-8", "PMC4907027", "27296719"]}, {"Citation": "Ram\u00edrez J., Celis R., Usategui A., Ruiz-Esquide V., Far\u00e9 R., Cuervo A., Sanmart\u00ed R., Pablos J.L., Ca\u00f1ete J.D. Immunopathologic Characterization of Ultrasound-Defined Synovitis in Rheumatoid Arthritis Patients in Clinical Remission. Arthritis Res. Ther. 2016;18:74. doi: 10.1186/s13075-016-0970-9.", "ArticleIdList": ["10.1186/s13075-016-0970-9", "PMC4818452", "27036513"]}, {"Citation": "Arandjelovic S., McKenney K.R., Leming S.S., Mowen K.A. ATP Induces Protein Arginine Deiminase 2-Dependent Citrullination in Mast Cells through the P2X7 Purinergic Receptor. J. Immunol. 2012;189:4112\u20134122. doi: 10.4049/jimmunol.1201098.", "ArticleIdList": ["10.4049/jimmunol.1201098", "PMC3466374", "22984079"]}, {"Citation": "Rivellese F., Suurmond J., Habets K., Dorj\u00e9e A.L., Ramamoorthi N., Townsend M.J., De Paulis A., Marone G., Huizinga T.W.J., Pitzalis C., et al. Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses: Mast Cell Suppression of Monocyte Activation. Arthritis Rheumatol. 2015;67:2343\u20132353. doi: 10.1002/art.39192.", "ArticleIdList": ["10.1002/art.39192", "25989191"]}, {"Citation": "Ohtsubo-Yoshioka M., Nunomura S., Kataoka T.R., Okayama Y., Ra C. Fc Receptor Beta Chain Deficiency Exacerbates Murine Arthritis in the Anti-Type II Collagen Antibody-Induced Experimental Model. Mod. Rheumatol. 2013;23:804\u2013810. doi: 10.3109/s10165-012-0749-z.", "ArticleIdList": ["10.3109/s10165-012-0749-z", "23053716"]}, {"Citation": "Lee H., Kashiwakura J.-I., Matsuda A., Watanabe Y., Sakamoto-Sasaki T., Matsumoto K., Hashimoto N., Saito S., Ohmori K., Nagaoka M., et al. Activation of Human Synovial Mast Cells from Rheumatoid Arthritis or Osteoarthritis Patients in Response to Aggregated IgG through Fc\u03b3 Receptor I and Fc\u03b3 Receptor II. Arthritis Rheum. 2013;65:109\u2013119. doi: 10.1002/art.37741.", "ArticleIdList": ["10.1002/art.37741", "23055095"]}, {"Citation": "Suurmond J., Rivellese F., Dorj\u00e9e A.L., Bakker A.M., Rombouts Y.J.P.C., Rispens T., Wolbink G., Zaldumbide A., Hoeben R.C., Huizinga T.W.J., et al. Toll-like Receptor Triggering Augments Activation of Human Mast Cells by Anti-Citrullinated Protein Antibodies. Ann. Rheum. Dis. 2015;74:1915\u20131923. doi: 10.1136/annrheumdis-2014-205562.", "ArticleIdList": ["10.1136/annrheumdis-2014-205562", "24818634"]}, {"Citation": "Guma M., Kashiwakura J., Crain B., Kawakami Y., Beutler B., Firestein G.S., Kawakami T., Karin M., Corr M. JNK1 Controls Mast Cell Degranulation and IL-1\u03b2 Production in Inflammatory Arthritis. Proc. Natl. Acad. Sci. USA. 2010;107:22122\u201322127. doi: 10.1073/pnas.1016401107.", "ArticleIdList": ["10.1073/pnas.1016401107", "PMC3009768", "21135226"]}, {"Citation": "Kim H., Chung D. TLR4-Mediated IL-12 Production Enhances IFN-\u03b3 and IL-1\u03b2 Production, Which Inhibits TGF-\u03b2 Production and Promotes Antibody-Induced Joint Inflammation. Arthritis Res. Ther. 2012;14:R210. doi: 10.1186/ar4048.", "ArticleIdList": ["10.1186/ar4048", "PMC3580522", "23036692"]}, {"Citation": "Xu D., Jiang H.-R., Li Y., Pushparaj P.N., Kurowska-Stolarska M., Leung B.P., Mu R., Tay H.K., McKenzie A.N.J., McInnes I.B., et al. IL-33 Exacerbates Autoantibody-Induced Arthritis. J. Immunol. 2010;184:2620\u20132626. doi: 10.4049/jimmunol.0902685.", "ArticleIdList": ["10.4049/jimmunol.0902685", "20139274"]}, {"Citation": "Kim K.-W., Kim B.-M., Won J.-Y., Min H.-K., Lee K.-A., Lee S.-H., Kim H.-R. Regulation of Osteoclastogenesis by Mast Cell in Rheumatoid Arthritis. Arthritis Res. Ther. 2021;23:124. doi: 10.1186/s13075-021-02491-1.", "ArticleIdList": ["10.1186/s13075-021-02491-1", "PMC8059019", "33882986"]}, {"Citation": "Nile C.J., Barksby E., Jitprasertwong P., Preshaw P.M., Taylor J.J. Expression and Regulation of Interleukin-33 in Human Monocytes: IL-33 in Monocytes. Immunology. 2010;130:172\u2013180. doi: 10.1111/j.1365-2567.2009.03221.x.", "ArticleIdList": ["10.1111/j.1365-2567.2009.03221.x", "PMC2878462", "20070408"]}, {"Citation": "Liew F.Y. IL-33: A Janus Cytokine: Table 1. Ann. Rheum. Dis. 2012;71:i101\u2013i104. doi: 10.1136/annrheumdis-2011-200589.", "ArticleIdList": ["10.1136/annrheumdis-2011-200589", "22460136"]}, {"Citation": "Shakerian L., Kolahdooz H., Garousi M., Keyvani V., Kamal Kheder R., Abdulsattar Faraj T., Yazdanpanah E., Esmaeili S.-A. IL-33/ST2 Axis in Autoimmune Disease. Cytokine. 2022;158:156015. doi: 10.1016/j.cyto.2022.156015.", "ArticleIdList": ["10.1016/j.cyto.2022.156015", "36041312"]}, {"Citation": "Kenna T.J., Brown M.A. The Role of IL-17-Secreting Mast Cells in Inflammatory Joint Disease. Nat. Rev. Rheumatol. 2013;9:375\u2013379. doi: 10.1038/nrrheum.2012.205.", "ArticleIdList": ["10.1038/nrrheum.2012.205", "23229447"]}, {"Citation": "Hueber A.J., Asquith D.L., Miller A.M., Reilly J., Kerr S., Leipe J., Melendez A.J., McInnes I.B. Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium. J. Immunol. 2010;184:3336\u20133340. doi: 10.4049/jimmunol.0903566.", "ArticleIdList": ["10.4049/jimmunol.0903566", "20200272"]}, {"Citation": "Kan J., Mishima S., Kashiwakura J., Sasaki-Sakamoto T., Seki M., Saito S., Ra C., Tokuhashi Y., Okayama Y. Interleukin-17A Expression in Human Synovial Mast Cells in Rheumatoid Arthritis and Osteoarthritis. Allergol. Int. 2016;65:S11\u2013S16. doi: 10.1016/j.alit.2016.04.007.", "ArticleIdList": ["10.1016/j.alit.2016.04.007", "27209051"]}, {"Citation": "Russell F.A., Zhan S., Dumas A., Lagarde S., Pouliot M., McDougall J.J. The Pronociceptive Effect of Proteinase-Activated Receptor-4 Stimulation in Rat Knee Joints Is Dependent on Mast Cell Activation. Pain. 2011;152:354\u2013360. doi: 10.1016/j.pain.2010.10.038.", "ArticleIdList": ["10.1016/j.pain.2010.10.038", "21238854"]}, {"Citation": "Sawamukai N., Yukawa S., Saito K., Nakayamada S., Kambayashi T., Tanaka Y. Mast Cell-Derived Tryptase Inhibits Apoptosis of Human Rheumatoid Synovial Fibroblasts via Rho-Mediated Signaling. Arthritis Rheum. 2010;62:952\u2013959. doi: 10.1002/art.27331.", "ArticleIdList": ["10.1002/art.27331", "20131259"]}, {"Citation": "Chu Y., Wang J., Zhou X. Mast Cell Chymase in Synovial Fluid of Collagen-Induced-Arthritis Rats Regulates Gelatinase Release and Promotes Synovial Fibroblasts Proliferation via FAK/P21 Signaling Pathway. Biochem. Biophys. Res. Commun. 2019;514:336\u2013343. doi: 10.1016/j.bbrc.2019.04.121.", "ArticleIdList": ["10.1016/j.bbrc.2019.04.121", "31036322"]}, {"Citation": "Stevens R.L., McNeil H.P., Wensing L.A., Shin K., Wong G.W., Hansbro P.M., Krilis S.A. Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5. J. Biol. Chem. 2017;292:5392\u20135404. doi: 10.1074/jbc.M116.773416.", "ArticleIdList": ["10.1074/jbc.M116.773416", "PMC5392683", "28193842"]}, {"Citation": "Mehta P., Miszta P., Rzodkiewicz P., Michalak O., Krzeczy\u0144ski P., Filipek S. Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases. Life. 2020;10:50. doi: 10.3390/life10040050.", "ArticleIdList": ["10.3390/life10040050", "PMC7235846", "32344736"]}, {"Citation": "Nent E., Frommholz D., Gajda M., Br\u00e4uer R., Illges H. Histamine 4 Receptor Plays an Important Role in Auto-Antibody-Induced Arthritis. Int. Immunol. 2013;25:437\u2013443. doi: 10.1093/intimm/dxt008.", "ArticleIdList": ["10.1093/intimm/dxt008", "23545338"]}, {"Citation": "Palm A.-K.E., Garcia-Faroldi G., Lundberg M., Pejler G., Kleinau S. Activated Mast Cells Promote Differentiation of B Cells into Effector Cells. Sci. Rep. 2016;6:20531. doi: 10.1038/srep20531.", "ArticleIdList": ["10.1038/srep20531", "PMC4742803", "26847186"]}, {"Citation": "Hartkamp L.M., Fine J.S., Van Es I.E., Tang M.W., Smith M., Woods J., Narula S., DeMartino J., Tak P.P., Reedquist K.A. Btk Inhibition Suppresses Agonist-Induced Human Macrophage Activation and Inflammatory Gene Expression in RA Synovial Tissue Explants. Ann. Rheum. Dis. 2015;74:1603\u20131611. doi: 10.1136/annrheumdis-2013-204143.", "ArticleIdList": ["10.1136/annrheumdis-2013-204143", "24764451"]}, {"Citation": "Watterson S.H., De Lucca G.V., Shi Q., Langevine C.M., Liu Q., Batt D.G., Beaudoin Bertrand M., Gong H., Dai J., Yip S., et al. Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-Fluoro-1-Methyl-2,4-Dioxo-1,2-Dihydroquinazolin-3(4 H)-Yl)-2-Methylphenyl)-2-(S)-(2-Hydroxypropan-2-Yl)-2,3,4,9-Tetrahydro-1 H -Carbazole-8-Carboxamide (BMS-986142): A Reversible Inhibitor of Bruton\u2019s Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers. J. Med. Chem. 2016;59:9173\u20139200. doi: 10.1021/acs.jmedchem.6b01088.", "ArticleIdList": ["10.1021/acs.jmedchem.6b01088", "27583770"]}, {"Citation": "Pimentel T.A., Sampaio A.L.F., D\u2019Acquisto F., Perretti M., Oliani S.M. An Essential Role for Mast Cells as Modulators of Neutrophils Influx in Collagen-Induced Arthritis in the Mouse. Lab. Investig. 2011;91:33\u201342. doi: 10.1038/labinvest.2010.140.", "ArticleIdList": ["10.1038/labinvest.2010.140", "PMC3498880", "20714326"]}, {"Citation": "Bader-Meunier B., Bulai Livideanu C., Larroche C., Durieu I., Artru L., Beucher A., Cormier G., Cornec D., Delarco M., Dubost J.-J., et al. Association of Mastocytosis with Inflammatory Joint Diseases: A Series of 31 Patients. Semin. Arthritis Rheum. 2014;44:362\u2013365. doi: 10.1016/j.semarthrit.2014.05.016.", "ArticleIdList": ["10.1016/j.semarthrit.2014.05.016", "25037281"]}, {"Citation": "Rivellese F., Nerviani A., Rossi F.W., Marone G., Matucci-Cerinic M., De Paulis A., Pitzalis C. Mast Cells in Rheumatoid Arthritis: Friends or Foes? Autoimmun. Rev. 2017;16:557\u2013563. doi: 10.1016/j.autrev.2017.04.001.", "ArticleIdList": ["10.1016/j.autrev.2017.04.001", "28411167"]}, {"Citation": "Rivellese F., Rossi F.W., Galdiero M.R., Pitzalis C., De Paulis A. Mast Cells in Early Rheumatoid Arthritis. Int. J. Mol. Sci. 2019;20:2040. doi: 10.3390/ijms20082040.", "ArticleIdList": ["10.3390/ijms20082040", "PMC6515166", "31027208"]}, {"Citation": "Zhao Z., He S., Tang S., Lai X., Ren J., Yu X., Lin J., Wang M., El Akkawi M.M., Zeng S., et al. CLP1 Is a Prognosis-Related Biomarker and Correlates with Immune Infiltrates in Rheumatoid Arthritis. Front. Pharmacol. 2022;13:827215. doi: 10.3389/fphar.2022.827215.", "ArticleIdList": ["10.3389/fphar.2022.827215", "PMC9201986", "35721104"]}, {"Citation": "Rossini M., Viapiana O., Zanoni G., Tripi G., Idolazzi L., Fracassi E., Adami G., Adami S., Gatti D. Serum Levels of Tryptase Suggest That Mast Cells Might Have an Anti-inflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al.: LETTERS. Arthritis Rheumatol. 2016;68:769. doi: 10.1002/art.39506.", "ArticleIdList": ["10.1002/art.39506", "26606740"]}, {"Citation": "Mishima S., Kashiwakura J., Toyoshima S., Sasaki-Sakamoto T., Sano Y., Nakanishi K., Matsumoto K., Okayama Y. Higher PGD2 Production by Synovial Mast Cells from Rheumatoid Arthritis Patients Compared with Osteoarthritis Patients via MiR-199a-3p/Prostaglandin Synthetase 2 Axis. Sci. Rep. 2021;11:5738. doi: 10.1038/s41598-021-84963-7.", "ArticleIdList": ["10.1038/s41598-021-84963-7", "PMC7952410", "33707464"]}, {"Citation": "Rao S.M., Auger J.L., Gaillard P., Weissleder R., Wada E., Torres R., Kojima M., Benoist C., Mathis D., Binstadt B.A. The Neuropeptide Neuromedin U Promotes Autoantibody-Mediated Arthritis. Arthritis Res. Ther. 2012;14:R29. doi: 10.1186/ar3732.", "ArticleIdList": ["10.1186/ar3732", "PMC3392824", "22314006"]}, {"Citation": "Okamura Y., Mishima S., Kashiwakura J., Sasaki-Sakamoto T., Toyoshima S., Kuroda K., Saito S., Tokuhashi Y., Okayama Y. The Dual Regulation of Substance P-Mediated Inflammation via Human Synovial Mast Cells in Rheumatoid Arthritis. Allergol. Int. 2017;66:S9\u2013S20. doi: 10.1016/j.alit.2017.03.002.", "ArticleIdList": ["10.1016/j.alit.2017.03.002", "28366675"]}, {"Citation": "Xue L., Li X., Chen Q., He J., Dong Y., Wang J., Shen S., Jia R., Zang Q.J., Zhang T., et al. Associations between D3R Expression in Synovial Mast Cells and Disease Activity and Oxidant Status in Patients with Rheumatoid Arthritis. Clin. Rheumatol. 2018;37:2621\u20132632. doi: 10.1007/s10067-018-4168-1.", "ArticleIdList": ["10.1007/s10067-018-4168-1", "29934747"]}, {"Citation": "Wang B., Li X., Li M., Geng Y., Wang N., Jin Y., Zhang W., Xu K., Wang J., Tao L., et al. Dopamine D3 Receptor Signaling Alleviates Mouse Rheumatoid Arthritis by Promoting Toll-like Receptor 4 Degradation in Mast Cells. Cell Death Dis. 2022;13:240. doi: 10.1038/s41419-022-04695-y.", "ArticleIdList": ["10.1038/s41419-022-04695-y", "PMC8924203", "35292659"]}, {"Citation": "Chen S., Noordenbos T., Blijdorp I., Van Mens L., Ambarus C.A., Vogels E., Te Velde A., Alsina M., Ca\u00f1ete J.D., Yeremenko N., et al. Histologic Evidence That Mast Cells Contribute to Local Tissue Inflammation in Peripheral Spondyloarthritis by Regulating Interleukin-17A Content. Rheumatology. 2019;58:617\u2013627. doi: 10.1093/rheumatology/key331.", "ArticleIdList": ["10.1093/rheumatology/key331", "30517745"]}, {"Citation": "Noordenbos T., Blijdorp I., Chen S., Stap J., Mul E., Ca\u00f1ete J.D., Lubberts E., Yeremenko N., Baeten D. Human Mast Cells Capture, Store, and Release Bioactive, Exogenous IL-17A. J. Leukoc. Biol. 2016;100:453\u2013462. doi: 10.1189/jlb.3HI1215-542R.", "ArticleIdList": ["10.1189/jlb.3HI1215-542R", "27034403"]}, {"Citation": "Polivka L., Suranjith L., Jouzeau J.-Y., Hermine O., Moulin D. Mast Cells in Spondyloarthritis, More than Simple Inflammatory Bystanders? Ther. Adv. Musculoskelet. Dis. 2020;12:1759720X2097190. doi: 10.1177/1759720X20971907.", "ArticleIdList": ["10.1177/1759720X20971907", "PMC7675857", "33240405"]}, {"Citation": "Noordenbos T., Yeremenko N., Gofita I., Van De Sande M., Tak P.P., Ca\u0148ete J.D., Baeten D. Interleukin-17-Positive Mast Cells Contribute to Synovial Inflammation in Spondylarthritis. Arthritis Rheum. 2012;64:99\u2013109. doi: 10.1002/art.33396.", "ArticleIdList": ["10.1002/art.33396", "21968742"]}, {"Citation": "Mauro D., Thomas R., Guggino G., Lories R., Brown M.A., Ciccia F. Ankylosing Spondylitis: An Autoimmune or Autoinflammatory Disease? Nat. Rev. Rheumatol. 2021;17:387\u2013404. doi: 10.1038/s41584-021-00625-y.", "ArticleIdList": ["10.1038/s41584-021-00625-y", "34113018"]}, {"Citation": "Jiang J., Zhan X., Liang T., Chen L., Huang S., Sun X., Jiang W., Chen J., Chen T., Li H., et al. Dysregulation of SAA1, TUBA8 and Monocytes Are Key Factors in Ankylosing Spondylitis with Femoral Head Necrosis. Front. Immunol. 2022;12:814278. doi: 10.3389/fimmu.2021.814278.", "ArticleIdList": ["10.3389/fimmu.2021.814278", "PMC8812255", "35126370"]}, {"Citation": "Appel H., Maier R., Bleil J., Hempfing A., Loddenkemper C., Schlichting U., Syrbe U., Sieper J. In Situ Analysis of Interleukin-23- and Interleukin-12-Positive Cells in the Spine of Patients with Ankylosing Spondylitis: IL-23 in the Spine of Patients with AS. Arthritis Rheum. 2013;65:1522\u20131529. doi: 10.1002/art.37937.", "ArticleIdList": ["10.1002/art.37937", "23508523"]}, {"Citation": "Blauvelt A., Chiricozzi A. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clin. Rev. Allergy Immunol. 2018;55:379\u2013390. doi: 10.1007/s12016-018-8702-3.", "ArticleIdList": ["10.1007/s12016-018-8702-3", "PMC6244934", "30109481"]}, {"Citation": "Keijsers R.R.M.C., Joosten I., Van Erp P.E.J., Koenen H.J.P.M., Van De Kerkhof P.C.M. Cellular Sources of IL-17 in Psoriasis: A Paradigm Shift? Exp. Dermatol. 2014;23:799\u2013803. doi: 10.1111/exd.12487.", "ArticleIdList": ["10.1111/exd.12487", "25039885"]}, {"Citation": "Chimenti M.S., Sunzini F., Fiorucci L., Botti E., Fonti G.L., Conigliaro P., Triggianese P., Costa L., Caso F., Giunta A., et al. Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress. Front. Immunol. 2018;9:2363. doi: 10.3389/fimmu.2018.02363.", "ArticleIdList": ["10.3389/fimmu.2018.02363", "PMC6220124", "30429845"]}, {"Citation": "Kirkham B.W., Kavanaugh A., Reich K. Interleukin-17A: A Unique Pathway in Immune-Mediated Diseases: Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis. Immunology. 2014;141:133\u2013142. doi: 10.1111/imm.12142.", "ArticleIdList": ["10.1111/imm.12142", "PMC3904234", "23819583"]}, {"Citation": "Cannav\u00f2 S.P., Bertino L., Di Salvo E., Papaianni V., Ventura-Spagnolo E., Gangemi S. Possible Roles of IL-33 in the Innate-Adaptive Immune Crosstalk of Psoriasis Pathogenesis. Mediat. Inflamm. 2019;2019:7158014. doi: 10.1155/2019/7158014.", "ArticleIdList": ["10.1155/2019/7158014", "PMC6815589", "31736655"]}, {"Citation": "Tenazinha C., Barros R., Fonseca J.E., Vieira-Sousa E. Histopathology of Psoriatic Arthritis Synovium\u2014A Narrative Review. Front. Med. 2022;9:860813. doi: 10.3389/fmed.2022.860813.", "ArticleIdList": ["10.3389/fmed.2022.860813", "PMC9283901", "35847785"]}, {"Citation": "Hsu D.-Z., Chu P.-Y., Chen S.-J., Liu M.-Y. Mast Cell Stabilizer Ketotifen Inhibits Gouty Inflammation in Rats. Am. J. Ther. 2016;23:e1009\u2013e1015. doi: 10.1097/MJT.0b013e31829ea238.", "ArticleIdList": ["10.1097/MJT.0b013e31829ea238", "23884077"]}, {"Citation": "Hoffmeister C., Silva M.A., Rossato M.F., Trevisan G., Oliveira S.M., Guerra G.P., Silva C.R., Ferreira J. Participation of the TRPV1 Receptor in the Development of Acute Gout Attacks. Rheumatology. 2014;53:240\u2013249. doi: 10.1093/rheumatology/ket352.", "ArticleIdList": ["10.1093/rheumatology/ket352", "24185761"]}, {"Citation": "Reber L.L., Marichal T., Sokolove J., Starkl P., Gaudenzio N., Iwakura Y., Karasuyama H., Schwartz L.B., Robinson W.H., Tsai M., et al. Contribution of Mast Cell-Derived Interleukin-1\u03b2 to Uric Acid Crystal-Induced Acute Arthritis in Mice: MC-Derived IL-1\u03b2 in Mice with MSU Crystal-Induced Arthritis. Arthritis Rheumatol. 2014;66:2881\u20132891. doi: 10.1002/art.38747.", "ArticleIdList": ["10.1002/art.38747", "PMC4443497", "24943488"]}, {"Citation": "Hoffmeister C., Trevisan G., Rossato M.F., De Oliveira S.M., Gomez M.V., Ferreira J. Role of TRPV1 in Nociception and Edema Induced by Monosodium Urate Crystals in Rats. Pain. 2011;152:1777\u20131788. doi: 10.1016/j.pain.2011.03.025.", "ArticleIdList": ["10.1016/j.pain.2011.03.025", "21550723"]}, {"Citation": "Dalbeth N., Pool B., Gamble G.D., Smith T., Callon K.E., McQueen F.M., Cornish J. Cellular Characterization of the Gouty Tophus: A Quantitative Analysis. Arthritis Rheum. 2010;62:1549\u20131556. doi: 10.1002/art.27356.", "ArticleIdList": ["10.1002/art.27356", "20131281"]}, {"Citation": "Hildebrand K.A., Zhang M., Befus A.D., Salo P.T., Hart D.A. A Myofibroblast-Mast Cell-Neuropeptide Axis of Fibrosis in Post-Traumatic Joint Contractures: An In Vitro Analysis of Mechanistic Components: MYOFIBROBLAST-MAST CELL-NEUROPEPTIDE FIBROSIS. J. Orthop. Res. 2014;32:1290\u20131296. doi: 10.1002/jor.22676.", "ArticleIdList": ["10.1002/jor.22676", "24985721"]}, {"Citation": "Torre O.M., Mroz V., Bartelstein M.K., Huang A.H., Iatridis J.C. Annulus Fibrosus Cell Phenotypes in Homeostasis and Injury: Implications for Regenerative Strategies. Ann. N. Y. Acad. Sci. 2019;1442:61\u201378. doi: 10.1111/nyas.13964.", "ArticleIdList": ["10.1111/nyas.13964", "PMC6417974", "30604562"]}, {"Citation": "Lan T., Hu Z., Guo W., Yan B., Zhang Y. Development of a Novel Inflammatory-Associated Gene Signature and Immune Infiltration Patterns in Intervertebral Disc Degeneration. Oxid. Med. Cell. Longev. 2022;2022:2481071. doi: 10.1155/2022/2481071.", "ArticleIdList": ["10.1155/2022/2481071", "PMC9526649", "36193061"]}, {"Citation": "Zhu Z., He Z., Tang T., Wang F., Chen H., Li B., Chen G., Wang J., Tian W., Chen D., et al. Integrative Bioinformatics Analysis Revealed Mitochondrial Dysfunction-Related Genes Underlying Intervertebral Disc Degeneration. Oxid. Med. Cell. Longev. 2022;2022:1372483. doi: 10.1155/2022/1372483.", "ArticleIdList": ["10.1155/2022/1372483", "PMC9578809", "36267810"]}, {"Citation": "Peake J.M., Neubauer O., Della Gatta P.A., Nosaka K. Muscle Damage and Inflammation during Recovery from Exercise. J. Appl. Physiol. 2017;122:559\u2013570. doi: 10.1152/japplphysiol.00971.2016.", "ArticleIdList": ["10.1152/japplphysiol.00971.2016", "28035017"]}, {"Citation": "Duchesne E., Bouchard P., Roussel M.-P., C\u00f4t\u00e9 C.H. Mast Cells Can Regulate Skeletal Muscle Cell Proliferation by Multiple Mechanisms: Mast Cells and Muscle Healing. Muscle Nerve. 2013;48:403\u2013414. doi: 10.1002/mus.23758.", "ArticleIdList": ["10.1002/mus.23758", "23813613"]}, {"Citation": "Widner D.B., Liu C., Zhao Q., Sharp S., Eber M.R., Park S.H., Files D.C., Shiozawa Y. Activated Mast Cells in Skeletal Muscle Can Be a Potential Mediator for Cancer-associated Cachexia. J. Cachexia Sarcopenia Muscle. 2021;12:1079\u20131097. doi: 10.1002/jcsm.12714.", "ArticleIdList": ["10.1002/jcsm.12714", "PMC8350201", "34008339"]}, {"Citation": "Christensen J., Alfredson H., Andersson G. Protease-Activated Receptors in the Achilles Tendon\u2013A Potential Explanation for the Excessive Pain Signalling in Tendinopathy. Mol. Pain. 2015;11:13. doi: 10.1186/s12990-015-0007-4.", "ArticleIdList": ["10.1186/s12990-015-0007-4", "PMC4369088", "25880199"]}, {"Citation": "Zhu Y.X., Huang J.Q., Ming Y.Y., Zhuang Z., Xia H. Screening of Key Biomarkers of Tendinopathy Based on Bioinformatics and Machine Learning Algorithms. PLoS ONE. 2021;16:e0259475. doi: 10.1371/journal.pone.0259475.", "ArticleIdList": ["10.1371/journal.pone.0259475", "PMC8555777", "34714891"]}, {"Citation": "Pingel J., Wienecke J., Kongsgaard M., Behzad H., Abraham T., Langberg H., Scott A. Increased Mast Cell Numbers in a Calcaneal Tendon Overuse Model. Scand. J. Med. Sci. Sports. 2013;23:e353\u2013e360. doi: 10.1111/sms.12089.", "ArticleIdList": ["10.1111/sms.12089", "PMC4282450", "23889295"]}, {"Citation": "Del Buono A., Battery L., Denaro V., Maccauro G., Maffulli N. Tendinopathy and Inflammation: Some Truths. Int. J. Immunopathol. Pharmacol. 2011;24:45\u201350. doi: 10.1177/03946320110241S209.", "ArticleIdList": ["10.1177/03946320110241S209", "21669137"]}, {"Citation": "Kragsnaes M.S., Fredberg U., Stribolt K., Kjaer S.G., Bendix K., Ellingsen T. Stereological Quantification of Immune-Competent Cells in Baseline Biopsy Specimens from Achilles Tendons: Results from Patients with Chronic Tendinopathy Followed for More Than 4 Years. Am. J. Sports Med. 2014;42:2435\u20132445. doi: 10.1177/0363546514542329.", "ArticleIdList": ["10.1177/0363546514542329", "25081311"]}, {"Citation": "Dean B.J.F., Gettings P., Dakin S.G., Carr A.J. Are Inflammatory Cells Increased in Painful Human Tendinopathy? A Systematic Review. Br. J. Sports Med. 2016;50:216\u2013220. doi: 10.1136/bjsports-2015-094754.", "ArticleIdList": ["10.1136/bjsports-2015-094754", "26246419"]}, {"Citation": "Convente M.R., Chakkalakal S.A., Yang E., Caron R.J., Zhang D., Kambayashi T., Kaplan F.S., Shore E.M. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva: Depletion of Mast Cells and Macrophages Inhibits ho in Fop. J. Bone Miner. Res. 2018;33:269\u2013282. doi: 10.1002/jbmr.3304.", "ArticleIdList": ["10.1002/jbmr.3304", "PMC7737844", "28986986"]}, {"Citation": "Matsuo K., Chavez R.D., Barruet E., Hsiao E.C. Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification. Curr. Osteoporos. Rep. 2019;17:387\u2013394. doi: 10.1007/s11914-019-00541-x.", "ArticleIdList": ["10.1007/s11914-019-00541-x", "PMC7271746", "31721068"]}, {"Citation": "Kan L., Lounev V.Y., Pignolo R.J., Duan L., Liu Y., Stock S.R., McGuire T.L., Lu B., Gerard N.P., Shore E.M., et al. Substance P Signaling Mediates BMP-Dependent Heterotopic Ossification. J. Cell. Biochem. 2011;112:2759\u20132772. doi: 10.1002/jcb.23259.", "ArticleIdList": ["10.1002/jcb.23259", "PMC3508732", "21748788"]}, {"Citation": "De Ruiter R.D., Smilde B.J., Pals G., Bravenboer N., Knaus P., Schoenmaker T., Botman E., S\u00e1nchez-Duffhues G., Pacifici M., Pignolo R.J., et al. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop. Front. Endocrinol. 2021;12:732728. doi: 10.3389/fendo.2021.732728.", "ArticleIdList": ["10.3389/fendo.2021.732728", "PMC8631510", "34858325"]}, {"Citation": "Brock I., Prendergast W., Maitland A. Mast Cell Activation Disease and Immunoglobulin Deficiency in Patients with Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder. Am. J. Med. Genet. C Semin. Med. Genet. 2021;187:473\u2013481. doi: 10.1002/ajmg.c.31940.", "ArticleIdList": ["10.1002/ajmg.c.31940", "34747107"]}, {"Citation": "Kohn A., Chang C. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (HEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS) Clin. Rev. Allergy Immunol. 2020;58:273\u2013297. doi: 10.1007/s12016-019-08755-8.", "ArticleIdList": ["10.1007/s12016-019-08755-8", "31267471"]}, {"Citation": "Royer S.P., Han S.J. Mechanobiology in the Comorbidities of Ehlers Danlos Syndrome. Front. Cell Dev. Biol. 2022;10:874840. doi: 10.3389/fcell.2022.874840.", "ArticleIdList": ["10.3389/fcell.2022.874840", "PMC9081723", "35547807"]}, {"Citation": "Seneviratne S.L., Maitland A., Afrin L. Mast Cell Disorders in Ehlers-Danlos Syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 2017;175:226\u2013236. doi: 10.1002/ajmg.c.31555.", "ArticleIdList": ["10.1002/ajmg.c.31555", "28261938"]}, {"Citation": "Pyatilova P., Akin C., Alvarez-Twose I., Arock M., Bonadonna P., Brockow K., Butterfield J.H., Broesby-Olsen S., Carter M.C., Castells M., et al. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium. J. Allergy Clin. Immunol. Pract. 2022;10:2015\u20132024. doi: 10.1016/j.jaip.2022.05.037.", "ArticleIdList": ["10.1016/j.jaip.2022.05.037", "35724950"]}, {"Citation": "Afrin L.B. Some Cases of Hypermobile Ehlers\u2013Danlos Syndrome May Be Rooted in Mast Cell Activation Syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 2021;187:466\u2013472. doi: 10.1002/ajmg.c.31944.", "ArticleIdList": ["10.1002/ajmg.c.31944", "34719842"]}, {"Citation": "Bonamichi-Santos R., Yoshimi-Kanamori K., Giavina-Bianchi P., Aun M.V. Association of Postural Tachycardia Syndrome and Ehlers-Danlos Syndrome with Mast Cell Activation Disorders. Immunol. Allergy Clin. N. Am. 2018;38:497\u2013504. doi: 10.1016/j.iac.2018.04.004.", "ArticleIdList": ["10.1016/j.iac.2018.04.004", "30007466"]}, {"Citation": "Monaco A., Choi D., Uzun S., Maitland A., Riley B. Association of Mast-Cell-Related Conditions with Hypermobile Syndromes: A Review of the Literature. Immunol. Res. 2022;70:419\u2013431. doi: 10.1007/s12026-022-09280-1.", "ArticleIdList": ["10.1007/s12026-022-09280-1", "PMC9022617", "35449490"]}, {"Citation": "Mathias C.J., Owens A., Iodice V., Hakim A. Dysautonomia in the Ehlers\u2013Danlos Syndromes and Hypermobility Spectrum Disorders\u2014With a Focus on the Postural Tachycardia Syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 2021;187:510\u2013519. doi: 10.1002/ajmg.c.31951.", "ArticleIdList": ["10.1002/ajmg.c.31951", "34766441"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "21"}, {"Year": "2023", "Month": "8", "Day": "1"}, {"Year": "2023", "Month": "8", "Day": "3"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "10", "Minute": "45"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "10", "Minute": "44"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "1", "Minute": "19"}, {"Year": "2023", "Month": "8", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["37629547", "PMC10455104", "10.3390/life13081690", "life13081690"]}}], "PubmedBookArticle": []}